Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial
Clinical trial NCT06499870 · RECRUITING
Trial details
- NCT number
- NCT06499870
- Sponsor
- Sean Sachdev
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-06
- Primary completion
- 2030-11-19
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.